CMF regimen
WikiDoc Resources for CMF regimen |
Articles |
---|
Most recent articles on CMF regimen Most cited articles on CMF regimen |
Media |
Powerpoint slides on CMF regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on CMF regimen at Clinical Trials.gov Clinical Trials on CMF regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on CMF regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on CMF regimen Discussion groups on CMF regimen Patient Handouts on CMF regimen Directions to Hospitals Treating CMF regimen Risk calculators and risk factors for CMF regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for CMF regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:CMF; CMF Regimen; CMF regimen; CTX/5-FU/MTX; Cyclophosphamide/Fluorouracil/Methotrexate; Cytoxan-Methotrexate-Fluorouracil Regimen
Overview
CMF regimen refers to a chemotherapy regimen consisting of cyclophosphamide, methotrexate, and fluorouracil, which may be used in the adjuvant setting for the treatment of nonmetastatic breast cancer or alone for the treatment of metastatic breast cancer.[1]
Regimen
CCyclophosphamide
MMethotrexate
FFluorouracil